InnoCare Pharma Limited
INCPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40,232,234 | $39,474,743 | $33,267,830 | $36,535,297 |
| - Cash | $6,222,626 | $8,224,596 | $8,697,927 | $5,928,716 |
| + Debt | $1,271,545 | $1,349,311 | $1,252,719 | $1,268,342 |
| Enterprise Value | $35,281,153 | $32,599,458 | $25,822,622 | $31,874,923 |
| Revenue | $1,009,448 | $738,537 | $625,404 | $1,043,033 |
| % Growth | 36.7% | 18.1% | -40% | – |
| Gross Profit | $871,007 | $610,102 | $482,007 | $977,366 |
| % Margin | 86.3% | 82.6% | 77.1% | 93.7% |
| EBITDA | -$312,545 | -$516,554 | -$808,279 | -$167,203 |
| % Margin | -31% | -69.9% | -129.2% | -16% |
| Net Income | -$440,633 | -$631,263 | -$886,593 | -$64,545 |
| % Margin | -43.7% | -85.5% | -141.8% | -6.2% |
| EPS Diluted | -0.26 | -0.37 | -0.6 | -0.037 |
| % Growth | 29.7% | 38.3% | -1,539.3% | – |
| Operating Cash Flow | -$365,551 | -$671,340 | -$565,554 | $167,058 |
| Capital Expenditures | -$78,231 | -$254,655 | -$370,327 | -$167,069 |
| Free Cash Flow | -$443,782 | -$925,995 | -$935,881 | -$11 |